108 related articles for article (PubMed ID: 38723996)
1. Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis.
Danzeng A; Guo L; Yang ZH; He ZW; Zeng CL; Ciren P; Lan RH; Jiang XW; Wang C; Zhang BH
J Gastrointest Surg; 2024 May; ():. PubMed ID: 38723996
[TBL] [Abstract][Full Text] [Related]
2. Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy.
Dai MG; Liu SY; Lu WF; Liang L; Ye B
Clin Med Insights Oncol; 2023; 17():11795549231180351. PubMed ID: 37342206
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit from adjuvant TACE combined with Lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy.
Liang L; Xu ZD; Lu WF; Du CF; Gao ZY; Huang XK; Wang KD; Ye TW; Dai MG; Liu SY; Shen GL; Liu JW; Zhang CW; Huang DS
Asian J Surg; 2024 May; ():. PubMed ID: 38724372
[TBL] [Abstract][Full Text] [Related]
5. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
6. Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior?
Wang H; Feng LH; Qian YW; Cao ZY; Wu MC; Cong WM
Ann Transl Med; 2019 Sep; 7(18):428. PubMed ID: 31700864
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis.
Ouyang J; Wang Z; Yuan K; Yang Y; Zhou Y; Li Q; Yang N; Zhao H; Zhao H; Zhou J
J Hepatocell Carcinoma; 2023; 10():1465-1477. PubMed ID: 37701564
[TBL] [Abstract][Full Text] [Related]
8. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus-related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection.
Bai S; Hu L; Liu J; Sun M; Sun Y; Xue F
Front Oncol; 2022; 12():919824. PubMed ID: 35898866
[TBL] [Abstract][Full Text] [Related]
10. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
[TBL] [Abstract][Full Text] [Related]
11. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
12. Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion.
Wang H; Qian YW; Wu MC; Cong WM
J Gastrointest Surg; 2020 Dec; 24(12):2737-2747. PubMed ID: 31768830
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion.
Tao C; Zhang K; Tao Z; Liu Y; Wu A; Wang L; Feng Q; Wu F; Rong W; Wu J
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1928. PubMed ID: 37906430
[TBL] [Abstract][Full Text] [Related]
15. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.
Wang L; Chen B; Li Z; Yao X; Liu M; Rong W; Wu F; Lin S; Liu Y; Zheng Y; Li Y; Wang W; Wu J
Onco Targets Ther; 2019; 12():1237-1247. PubMed ID: 30863091
[TBL] [Abstract][Full Text] [Related]
16. Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion.
Li HH; Qi LN; Ma L; Chen ZS; Xiang BD; Li LQ
Onco Targets Ther; 2018; 11():4747-4754. PubMed ID: 30127623
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.
Zhang XP; Chai ZT; Gao YZ; Chen ZH; Wang K; Shi J; Guo WX; Zhou TF; Ding J; Cong WM; Xie D; Lau WY; Cheng SQ
HPB (Oxford); 2019 Dec; 21(12):1687-1696. PubMed ID: 31153833
[TBL] [Abstract][Full Text] [Related]
19. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
Xiang C; Shen X; Zeng X; Zhang Y; Ma Z; Zhang G; Song X; Huang T; Yang J
Int J Surg; 2024 Jan; 110(1):315-323. PubMed ID: 37812183
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
